Gilead trades that made millions on COVID-19 drug news raise eyebrows
Well-timed trades in Gilead Sciences Inc’s options ahead of good news on the biopharmaceutical company’s COVID-19 drug treatment may draw regulatory scrutiny, experts...
Read MorePosted by Reuters | Jun 1, 2020 | World News |
Well-timed trades in Gilead Sciences Inc’s options ahead of good news on the biopharmaceutical company’s COVID-19 drug treatment may draw regulatory scrutiny, experts...
Read MorePosted by Reuters | Jun 1, 2020 | World News |
Oil prices were steady on Monday helped by reports that OPEC and Russia were closer to a deal on extending oil cuts but held back by renewed tension between the United States and...
Read MorePosted by Reuters | Jun 1, 2020 | World News |
Walmart Inc’s Indian e-commerce unit Flipkart said on Monday it would re-apply for a food retail license in India after reports said its earlier proposal was rejected by the government last...
Read MorePosted by Reuters | Jun 1, 2020 | World News |
There is broad backing in markets for cutting trading hours in a coordinated way across European exchanges, the London Stock Exchange said on...
Read MorePosted by Reuters | Jun 1, 2020 | World News |
As U.S. businesses reopen after weeks of pandemic lockdowns, many have been posting coronavirus disclaimers or requiring employees and patrons to sign waivers before...
Read More